The FDA will meet to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr. One panel member is Bobby Harshbarger, a Tennessee state senator who has multiple connections to the industry.
Doctors must deliver more bad news to patients, as a worldwide cancer drug shortage hits Nashville
Two of the most common chemotherapy drugs — including the only drug known to cure testicular cancer — are in short supply. It means oncologists are having to ration drugs and tweak treatment plans.
BioMimetic Continues Trying for Augment Approval
Brentwood-based BioMimetic has filed yet another round of paperwork in hopes of gaining federal approval for its bone graft therapy, called Augmentin.
On Air - 90.3 WPLN-FM